We report use of PEG-DSPE coated oxidized graphene nanoribbons (O-GNR-PEG-DSPE) as agent for delivery of anti-tumor drug Lucanthone (Luc) into Glioblastoma Multiformae (GBM) cells targeting base excision repair enzyme APE-1 (Apurinic endonuclease-1). Lucanthone, an endonuclease inhibitor of APE-1, was loaded onto O-GNR-PEG-DSPEs using a simple non-covalent method. We found its uptake by GBM cell line U251 exceeding 67% and 60% in APE-1-overexpressing U251, post 24 h. However, their uptake was~38% and 29% by MCF-7 and rat glial progenitor cells (CG-4), respectively. TEM analysis of U251 showed large aggregates of O-GNR-PEG-DSPE in vesicles. Luc-O-GNR-PEG-DSPE was significantly toxic to U251 but showed little/no toxicity when exposed to MCF-7/CG-4 cells. This differential uptake effect can be exploited to use O-GNR-PEG-DSPEs as a vehicle for Luc delivery to GBM, while reducing nonspecific cytotoxicity to the surrounding healthy tissue. Cell death in U251 was necrotic, probably due to oxidative degradation of APE-1.
1
Although there is evidence both for and against a correlation between APE-1 levels and radioresistance in tumors, 2 an inverse relationship between the expression level of APE-1 and radiation and chemotherapy responses has been observed in medulloblastoma and primitive neuroectodermal tumors. 1 In vitro studies have also shown that APE-1 contributes to the glioma cell resistance in response to alkylating agents therapy, and its endonuclease activity is increased by oxidative stress. 3 Previously, we 4 and others 5, 6 had demonstrated a correlation between base excision repair protein APE-1 and radiation sensitivity with GBM cell cultures. Also, we have shown that thioxanthenones such as lucanthone (CAS 479-50-5) and hycanthone (CAS 3105-97-3) inhibit the APE-1 endonuclease function in GBM cell lines with higher or overexpressed APE-1 levels without affecting its DNA substrate binding function. 7 As the next step, it is essential to determine whether we can use this mechanistic insight to cause tumor regression in mouse tumor models. However, as APE-1 is present both in normal and tumor cells, a way to target these thioxanthenones to GBM and other tumors specifically with no/ minimal damage to the surrounding normal tissue is needed.
Graphene, a two dimensional, single layer, hexagonal lattice of carbon atoms has attracted much attention due to its unique chemical and physical properties. 8 Studies have also established that graphene can be used in various biomedical applications such as imaging and drug delivery. [9] [10] [11] The large surface of graphene can be chemically modified with a wide variety of molecules that can enhance biocompatibility, 12 solubility, 13 or allow the targeting to specific cell types and hence proves to be a good platform for biomedical use. 14 Reports show that oxidized graphene nanoplatelets synthesized by modified Hummer's method (chemical oxidation of graphite followed by ultrasonic cleavage) and coated with the amphiphilic polymer 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol (DSPE-PEG) can load high amounts of aromatic molecules such as the drug doxorubicin and release them into tumor cells. 13, 15 The loading of the drug is achieved through the pi-stacking, a non-covalent interaction between electrons in adjacent pi bonds. 13, 15 Recently, Kosynkin and co-workers have pioneered a method that allows the synthesis of oxidized graphene nanoribbons (O-GNRs) in macroscopic amounts by the longitudinal unzipping of multi walled carbon nanotubes. 16 Our recent in vitro studies indicate that these nanoparticles coated with PEG-DSPE (hereafter called O-GNR-PEG-DSPE) may also be suitable for cell specific drug delivery. 17 In this paper, we report the efficacy of O-GNR-PEG-DSPE to load and deliver Luc to the GBM cell line U251.
Methods

Reagents
Cell line U251 and reagents used for measuring endonuclease activity were as described previously.
7 CG-4, rat glial progenitor cell line that remains a progenitor for only about 20-25 passages was kind gift from Dr. Toru Ogata from Research Institute, Namiki, Tokorozawa-City, Japan. Luc obtained from Dr. S. Archer (Sterling-Winthrop Research Institute, Rensselaer, NY) were maintained at 4°C under hygroscopic conditions, and dissolved in 1.2 mg/mL PEG-DSPE (in double distilled water) just prior to reactions. Plasmids consisting of full length APE-1 in pCMV10 were a kind gift from Dr. Bruce Demple (Stony Brook University, NY). Multi-walled carbon nanotubes and propidium iodide (PI) were obtained from Sigma Aldrich. All cell culture components were obtained from GIBCO. Annexin V/PI staining kits were obtained from Trevigen.
Cell culture
U251 transfected with either the blank plasmid pCMV10 (CMV/ U251) or full length APE-1 in pCMV10 (AI-5/CMV/U251) were grown in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum and 800 μg/ml of G418. CG-4 were grown in 70% of DMEM F12 containing 1X penicillinstreptomycin (100 μg/ml Streptomycin + 100 U of penicillin) (PS) with 1X N2 supplement (containing 1 mM Transferrin, 0.06 mM Insulin, 0.002 mM progesterone, 10 mM putresceine and 0.003 mM selenite) and 30% of B104 conditioned medium. MCF-7 were grown at 37°C in a humidified atmosphere of 5% CO 2 in RPMI medium supplemented with 10% fetal bovine serum and 1X PS.
O-GNR synthesis
O-GNRs were synthesized from multi-walled carbon nanotubes (MWCNTs)(Sigma-Aldrich, Length = 5-9 μm) using the oxidative longitudinal unzipping method. 16 Briefly, MWCNTs (150 mg) were suspended in 30 ml concentrated (96%) H 2 SO 4 . After 4 h, 4.75 mM KMnO 4 was added slowly and stirred for an h followed by further stirring for another h at 55-70°C in an oil bath. This solution was poured on ice (400 ml) containing 5 mL 30% H 2 O 2 and the ice-H 2 O 2 slurry was allowed to melt. The solution obtained was centrifuged at 3000 rpm for 30 minutes, after which the supernatant was discarded. The pellet obtained was then washed with 36% HCl. Ethanol and ether washes were used for flocculation and the final product (O-GNR) was obtained as pellet after centrifugation (30 minutes, 3000 rpm). This product was dried overnight in a vacuum oven at 60°C.
O-GNRs were characterized using atomic force microscopy (AFM) and transmission electron microscopy (TEM). AFM images were obtained using a Nano Surf Easy Scan 2 AFM (NanoScience Instruments Inc, Phoenix, AZ) operating in tapping mode using a V-shaped cantilever and TEM images were obtained using a Tecnai Bio Twin G transmission electron microscope (FEI, Hillsboro, OR), at 80 kV.
Luc loading on O-GNR-PEG-DSPE
Powdered O-GNRs were dispersed in a solution of 1.2 mg/mL 1, 2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino (polyethylene glycol)) (PEG-DSPE), at a concentration of 1 mg/mL. This dispersion was bath sonicated for 30 minutes to produce O-GNR-PEG-DSPE. 1 mg/mL solution of Luc in 1.2 mg/mL PEG-DSPE served as a Luc stock solution. 200 μL of the O-GNR-PEG-DSPE solution and 400 μL of the Luc solution were combined in a 20 mL glass vial, and the total volume was made up to 1 mL using a stock solution of 1.2 mg/mL PEG-DSPE and stirred at 4°C for 24 h. After this loading period, unincorporated Luc was separated out from the loaded O-GNRs by centrifugation at 13000 RPM for 1 hour. In order to calculate the loading efficiency, the absorbance of the supernatant was measured at 328 nm using an Evolution 300 UV-vis Spectrophotometer (Thermo Fisher Scientific, Waltham, MA) and compared to a standard curve. The loading efficiency was calculated by subtracting the unloaded Luc from the total available Luc. Loaded O-GNR-PEG-DSPEs were left in pellet form until used.
Uptake of O-GNR-PEG-DSPE in the U251 and CG-4 cell lines (using flow cytometry) O-GNR-PEG-DSPEs were loaded with PI and purified using the same method used for Luc loading. CMV/U251 and A1-5/ CMV/U251 were grown in 10 cm dishes at 37°C and 5% CO 2 in DMEM. Cells were either incubated with PI-loaded O-GNR-PEG-DSPEs at a concentration of 40 μg per mL (previously reported to be a non-toxic concentration) (15) of media, or left untreated. After 24 h, cells were trypsinized, resuspended in FACS buffer (1X PBS containing 20% fetal bovine serum) and placed on ice. Flow cytometry was performed immediately after all samples were prepared using a FACS Calibur Cell Sorter (BD Biosciences, San Jose, CA).
Transmission electron microscopy
Six well plates with surfaces covered with ACLAR® film (Electron Microscopy Sciences, Hatford, PA) were plated with CMV/U251 and MCF-7 cells at a density of 5 × 10 5 cells per plate, and exposed to O-GNR-PEG-DSPE for 3 h. At the end of 3 h, cells were fixed with 2.5% electron microscopy grade glutaraldehyde (Electron Microscopy Sciences, Hatford, PA) in 1 × PBS. After fixation, the films containing fixed cells were placed in 2% osmium tetroxide in 1X PBS, dehydrated through graded ethanol washes, and embedded in durcupan resin (Sigma-aldrich, St. Louis, USA). Areas with high cell densities were blocked, cut into 80 nm ultra-thin sections using an Ultracut E microtome (Reichert-Jung, Cambridge, UK), and placed on formvar-coated copper grids. The sections were then viewed with a Tecnai Bio Twin G transmission electron microscope (FEI, Hillsboro, OR), at 80 kV. Digital images were acquired using an XR-60 CCD digital camera system (AMT, Woburn, MA).
PrestoBlue assay
In separate cultures Luc alone (80 μM), 80 μM Luc loaded O-GNR-PEG-DSPE and O-GNR-PEG-DSPE (same weight as used for Luc loading) were incubated with CMV/U251, A1-5/CMV/U251, MCF-7 and CG-4 cells (5 × 10 3 cells per well in 96 well plates) for 24 h. Following the incubation period the media was removed and the cells were washed twice with 1 × PBS. 100 μL of fresh media was added to each well and 10 μl of PrestoBlue reagent was added to it and incubated for 4 h. Fluorescence was measured by Cytofluor fluorescence multiwell plate reader (Infinite M200, Tecan Group Ltd, NC, USA) with excitation at 530 nm, and emission at 580 nm. The cell viability in terms of % of unexposed cells is expressed as the percentage of (F test -F blank )/(F control -F blank ), where F test is the fluorescence of the cells exposed to nanoribbon-drug sample, F control is the fluorescence of the untreated sample and F blank is the fluorescence of the wells without any cells. The presto blue reading for all lysed cells was also taken for comparison.
MCF-7-CMV/U251 and CG-4-CMV/Co-Culture MCF-7, CG-4 and CMV/U251 were seeded separately on 12 mm round glass coverslips (Fisherbrand, Fisher Scientific, PA) in 100 mm plates at a density of 2.2 × 10 6 cells and allowed to grow overnight. For the two separate co-culture condition experiments, one coverslip from each cell line was placed in 6 well plates, for a total of two coverslips per well. These cells were then incubated with Luc alone (80 μM), 80 μM Luc loaded O-GNR-PEG-DSPE or O-GNR-PEG-DSPE for 24 h. After the incubation period, the media was removed and the cells were washed twice with 1 × PBS. Each coverslip was then transferred to its own well in 6 well plates containing 3 mL of media and 300 μL of PrestoBlue reagent. After incubating for 4 h, the fluorescence intensity was recorded using the procedure described above.
Annexin V/PI staining
Luc alone and Luc-loaded O-GNR-PEG-DSPEs at different concentrations (5-80 μM) were incubated with CMV/U251, A1-5/CMV/U251 and CG-4 (5 × 10 5 cells/ 3 ml in 6-well plates) for 4 h. Unexposed cells were used as control. Unloaded O-GNR-PEG-DSPEs in amounts equivalent to the loaded nanoparticles were also exposed to all the cell types as delivery agent control. The viability of the cells was analyzed by flow cytometry after Annexin V/PI staining using FACS Calibur Cell Sorter (BD Biosciences, San Jose, CA).
Statistics
PrestoBlue data is presented as mean ± standard deviation (n = 6). Student t test was used to analyze the differences among groups. One-way ANOVA followed by Tukey Kramer post hoc analysis was used for multiple comparisons between groups. All statistical analyses were performed using a 95% confidence interval (P b 0.05). 
Results
AFM and TEM analysis of O-GNRs
Luc loading on O-GNRs
Using a standard curve of Luc, and employing a previously determined ideal ratio of 1:1.5 of Luc: O-GNR it was determined that O-GNR-PEG-DSPE could load 310 μM of Luc per mg ( Figure S1 ). For a schematic of the loading process, see Figure 1 , C.
Uptake of O-GNR-PEG-DSPEs in U251 cells
PI is a DNA intercalating fluorescent dye that it is normally excluded from live cells. However, when conjugated to a delivery agent such as O-GNR-PEG-DSPE it can enter live, intact cells. Figure 2 showing the flow cytometry analysis of U251 and CG-4 incubated with PI loaded O-GNR-PEG-DSPE revealed that~60 % of A1-5/CMV/ U251 showed uptake of PI-loaded O-GNR-PEG-DSPEs, while~67 % of CMV/U251 showed uptake. However, onlỹ 38% of MCF and~29% of CG-4 showed uptake of the PI loaded O-GNR-PEG-DSPE. MCF-7-CMV/U251 and CG-4-CMV/U251 co-cultures Figure 3 , E shows that MCF-7 and CMV/U251 treated with 80 μM Luc exhibit a viability of~36% and~28% respectively when compared to untreated controls. CMV/U251 still exhibited significant decreased viability when exposed to Luc-loaded O-GNR-PEG-DSPE, with only~56% viability compared to untreated control. However, MCF-7 exposed to Luc-loaded O-GNR-PEG-DSPE do not exhibit decreased viability compared to untreated controls. O-GNR-PEG-DSPE alone was not toxic to either cell line. This trend held true for the CG-4 and CMV/U251 co-culture also (Figure 3, F) . CG-4 and CMV/U251 treated with 80 μM Luc exhibit a viability of~30% and~15% respectively when compared to untreated controls. CMV/U251 exhibited significant decreased viability when exposed to Luc-loaded O-GNR-PEG-DSPE, with only~29% viability compared to untreated control. However, CG-4 exposed to Luc-loaded O-GNR-PEG-DSPE showed~78% viability compared to untreated controls, although this difference was not statistically significant.
PrestoBlue assay to assess cell death
PrestoBlue is a resazurin dye based cell viability assay in which healthy cells with normal metabolic activity and mitochondrial integrity can convert resazurin in the assay reagent to a pink fluorescent dye. The amount of nonfluorescence to fluorescence conversion is directly proportional to the number of healthy cells present. Figure 4 , A and B shows that CMV/U251 and A1-5/CMV/U251 show a viability of~40% and~30% compared to untreated controls when exposed to 80 μM of free Luc which changes to~70% viability for both cell lines when the drug is loaded onto O-GNR-PEG-DSPE. Annexin V/PI staining of U251 cells exposed to free or loaded drug Annexin V (AV) is a 35 KDa phospholipid binding protein with a high affinity for phospatidyl serine. 18 Early apoptotic cells show exposed phosphotidyl serine on their cell surface while it is still intact. PI on the other hand can only enter dead cells or early necrotic cells with compromised membranes. Thus, in flow cytometry AV +/PI + represents dead cells, AV +/PI-represents cells in early apoptosis, AV-/PI + represents dead or necrotic cells with compromised membranes, and AV-/PI-represents healthy living cells. Flow cytometry of CMV/U251 exposed to 5-80 μM Luc showed a concentration dependent decrease in AV-/PI-cells with no healthy living cells remaining after 4 h of exposure to 80 μM of the drug. However, 37% of cells were still living after 4 h of exposure to O-GNR-PEG-DSPE loaded with 80 μM Luc. APE-1 overxpressing AI-5/CMV/U251 also showed a concentration dependent decrease in cell viability with 100% cell death occurring at 40 μM exposure for 4 h. However, exposure of these cells to Luc loaded nanoparticles showed 56% and 43% of the exposed cells were still living after 4 h of exposure to O-GNR-PEG-DSPE loaded with 40 μM and 80 μM Luc respectively (Table 1) . Exposure of the cells to 
Discussion
The efficient delivery of thioxanthanones like Luc and its analogues to GBM tumors for effective inhibition of overexpressed APE-1 requires a drug delivery agent that is stable in aqueous solutions, loads high concentrations of the drug, and can be easily taken up by the tumor cells. Also, there should be a slow, sustained and controlled release of the drug so as to decrease the non-specific release of the drug before reaching its target site. Most importantly, the agent should be easy to functionalize by targeting groups so that the efficiency of targeting can be improved. A recent review by Zhou et al. 19 elegantly presents updates on novel strategies for GBM therapy, delineating those where nanoparticles are introduced systemically, where this approach has been working some times, but the percentage of intravenously administered particles that enter the brain is very low. 20 It is not yet clear whether enough of the drug can be delivered by systemically-administered nanoparticles for treating tumors in the brain, although there is some evidence that systemically-administered nanoparticles are useful for diagnostic purposes, such as iron oxide-containing nanoparticles that facilitate imaging of brain tumors. 21 Another approach has delivered the nanoparticles directly into the brain, perhaps using Convection enhanced delivery (CED) to facilitate the distribution of the nanoparticles throughout the volume of the brain that needs therapy. 22 O-GNRs with their large surface area provide a suitable platform for loading Luc through pi stacking interactions. The non-covalent coating of PEG-DSPE on the O-GNRs also ensures that they are stable in aqueous suspension. We could load as high 310 μM of Luc onto each milligram of O-GNR-PEG-DSPE. Other thioxanthanones (hycanthone and its structural analogue Inadazole-6 (IA-6)) with similar structure are expected to have similar loading efficiency on O-GNR-PEG-DSPE.
We have recently shown that O-GNR-PEG-DSPEs show differential uptake based on cell type and thus cannot be taken up by all cells. 17 This is probably due to the fact that O-GNR-PEGDSPEs are relatively large sized nanoparticles (between 0.5-2.5 μm in length, Figure 1 ). As such, it is likely that they are taken up by specialized receptor mediated uptake mechanisms or by macropinocytotic mechanisms. 23 Flow cytometry based analysis showed that~67% of CMV/U251 and~60% of A1-5/CMV/U251 cells showed presence of these particles after 24 h proving that these particles get taken up by U251 (Figure 2 ). This could be due to the presence of specific receptors on the surface of U251 that promote uptake of these particles through receptor mediated endocytosis or induce a macropinocytotic response as we had reported before for uptake of these particles in HeLa cells. 17 In comparison only~38% of MCF-7 and~29% of CG-4 showed presence of O-GNR-PEG-DSPE in them indicating that these particles have a cell specific higher uptake in the GBM cell lines (Figure 2) .
One major objective for targeted drug delivery of Luc is to decrease the side effects caused by unwanted uptake of Luc by normal tissue. Unwanted uptake of Luc can be prevented if the drug delivery agent has an inherent low uptake in normal tissue and enhanced with slower release of the drug slowly so that once injected intravenously they will release the maximum load of drug only after being taken up by the tumor. TEM images of CMV/U251 showed that these cells could take up large aggregates whereas MCF-7/CG-4 failed to do so resulting in accumulation of large O-GNR-PEG-DSPE aggregates on the surface (Figure 3 ). This further indicates that CMV/U251 might have some specialized mechanism for the uptake of larger O-GNR-PEG-DSPE aggregates. Uptake of large aggregates would mean better drug delivery and hence more efficient APE-1 inhibition in CMV/U251. PrestoBlue assay of the four cell lines (U251, A1-5/U251, MCF-7 and CG-4) exposed to free Luc (80 μM) and Luc(80 μM) loaded on O-GNR-PEG-DSPE showed that loading decreased the toxicity of Luc by~30% in U251 cells and~40% in APE-1 overexpressing U251 cells compared to free drug (Figure 4) . However, the cell death observed in the drug loaded nanoparticles was significantly higher compared to unexposed cells (Figure 4 ). Luc loaded O-GNR-PEG-DSPE did not show high toxicity in CG-4 and MCF-7 cells although the free drug was toxic to them, due to lower uptake of Luc-O-GNR-PEG-DSPE uptake in these cells (Figure 2 ). This differential uptake phenomenon held true even when MCF-7 and CMV/U251 cells were exposed to Luc-O-GNR-PEG-DSPE together as co-culture. Although CMV/ U251 exposed to 80 μM Luc loaded on O-GNR-PEG-DSPE exhibited only~56% viability compared to untreated control, MCF-7 exposed to Luc-loaded O-GNR-PEG-DSPE in the same wells as CMV/U251 did not show significantly reduced viability compared to untreated controls (Figure 3, E) . This differential uptake and toxicity was further confirmed when CG-4 also showed much lower toxicity compared to CMV/U251 in coculture (Figure 3, F) . Taken together, the TEM images and cell viability experiments indicate that U251 have higher uptake of drug loaded O-GNR-PEG-DSPE and hence shows higher cell death.
To test the mechanism of cell death induced by the drug loaded onto O-GNR-PEG-DSPE we compared the effect of different concentrations (5-80 μM) of free Luc and Luc loaded onto nanoparticles, when exposed for 4 h to CMV/U251 and AI-5/CMV/U251 using Annexin V/PI staining. As expected the U251 were sensitive to the free Luc with 100% cell death observed at 80 μM in CMV/U251 and 40 μM free drug concentration in AI-5/CMV/U251. The A1-5 overexpressor was more sensitive to free Luc most likely owing to about 35 fold higher expression of APE-1 in this overexpressor U251 clone. 4 Exposure of CMV/U251 to Luc loaded O-GNR-PEG-DSPE showed an increase in cell viability by~64% at 5 μM and~37% at 80 μM (Figure 4) . Similarly, APE-1 overexpressing AI-5/ CMV/U251 showed an increase in cell viability by 53% at 5 μM and~43% at 80 μM (Figure 4 ) of loaded drug compared to free drug at the same concentrations. We also compared the toxicity of various weights of O-GNR-PEG-DSPE used to load 5-80 μM Luc on CMV/U251. O-GNR-PEG-DSPE showed negligible toxicity at all weights tested proving that the toxicity observed was primarily due to the released Luc. This also indicated that loading Luc onto O-GNR-PEG-DSPE does not affect its activity and thus the decrease in cell death may be due to the lower uptake of particles or slower release of Luc from O-GNR-PEG-DSPE. To ensure this differential toxicity observed is not due to lesser uptake of the O-GNR-PEG-DSPE particles we repeated the toxicity based drug delivery experiments on HeLa cells which we have previously shown to be able take up these particles. 17 Analysis of presto blue cell viability assay showed that cell death observed after 24 h of exposure to 3.1 μM of Luc loaded onto O-GNR-PEG-DSPE was significantly lesser than both 1.55 μM (50% of loaded) and 3.1 μM (same as loaded) of free drug showing that the decrease in toxicity observed was not due to low uptake of nanoparticles ( Figure S3 ). Thus we hypothesize that the decrease in cell death observed in drug loaded O-GNR-PEG-DSPE may be due to slower release of the drug from the particles. Further experiments are needed to confirm this hypothesis.
Another important observation from Annexin V/PI results was that almost all the dead cells exposed to either free drug or drug loaded onto O-GNR-PEG-DSPE were PI +/AV-suggesting that the cell death was necrotic ( Figure 5 ). Necrotic cell death is generally triggered by external factors or factors that cause damage to internal functioning of the cell through generation of stress and ultimately breakdown of cellular machinery. 24 We had reported earlier that Luc leads to an oxidative stress mediated degradation of APE-1 which might be causing the necrosismediated death observed. 7 Although, O-GNR-PEG-DSPE has been shown to be taken up only by certain cell types, 17 we can also functionalize it with groups that can increase their targeting efficiency to tumors. Such functionalization for the purpose of targeting have been reported previously for smaller graphene oxide nanoplatelets Table 1 Toxicity of lucanthone is reduced when coated on graphene nanoribbons (O-GNR) in GBM cell line U251.
Cell type
Lucanthone (μM) % PI-AV-% PI+ % Av+ % PI + AV+ CMV  C  79  10  4  6  5  2 0  7 8  0  1 7  10  5  95  0  0  20  3  97  0  0  40  3  97  0  0  80  0  95  5  0  A1-5  C  72  15  3  10  5 which are synthesized using Hummers method. 25 O-GNR-PEG-DSPE, with its large surface area can be similarly functionalized with antibodies targeting different tumors. The basis of functionalization is often to target receptors over-expressed on cancer cells using antibodies or groups that can bind to these receptors. For example, graphene oxide particles functionalized with antibodies against folate receptors have been used to target them to cancer cells over expressing folate receptors. [25] [26] [27] O-GNR-PEG-DSPE functionalized with antibodies against epidermal growth factor receptors which are often over expressed in GBM tumors can be utilized to increase their targeting to these tumors. 28 However, functionalization often leads to decreased drug loading efficiencies due to decrease in surface area available for drug loading.
Thus overall O-GNR-PEG-DSPE can be considered a good vessel for delivering Luc to GBM tumors. However, its further development as a drug delivery agent can take place only after optimization of efficacy, drug release kinetics and uptake in multiple tumor models and cell lines (GBM, neuroblastoma, prostate tumors, neural progenitor cell lines etc.) have been completed.
Our future research will also focus on the release kinetics of Luc from O-GNR-PEG-DSPEs to ensure prolonged suppression of the tumors. This will include studies that explore the pH dependency of drug release in vitro. Once we have established a clear kinetics for death of GBM cells through delayed release of Luc, we will use these Luc-loaded O-GNR-PEG-DSPEs for targeted delivery to orthotopic GBM tumors in mice.
